Female Average Life Expectancy in the US: What the Data Shows

Current national estimates and recent trends

Life expectancy for females in the United States reflects long-term improvements in medicine, public health, and social conditions, but progress has slowed and even reversed in recent years. Before the COVID-19 pandemic, U.S. female life expectancy had been stalling at historically high levels after decades of gradual gains. In the years following 2020, provisional data from the Centers for Disease Control and Prevention (CDC) show continued declines, followed by small recoveries, leaving levels below pre-pandemic baselines. These shifts are not uniform: they vary by age, race, ethnicity, income, education, and geography. Understanding these patterns helps explain what drives longevity and where public health efforts remain most needed.

Key definitions and measures used in U.S. life expectancy reporting

Life expectancy at birth is a statistical summary of the average number of years a person is expected to live if, at each age, they experience the current age-specific death rates throughout their lifetime. It is not a prediction for any individual, but a population-level measure. Important distinctions include:

• Period life expectancy: calculated using rates from a single point in time, reflecting current conditions.
• Life expectancy at age 65: often used to plan retirement and health care, since it captures years lived after typical workforce exit.
• Race and ethnicity reporting: data are commonly shown for non-Hispanic White, Black or African American, Hispanic, and Asian groups, recognizing that social and structural factors shape differences.

Verified numbers and recent data sources

Provisional 2022 final data from the National Center for Health Statistics (NCHS) represent the most recent finalized nationally representative estimates available as of mid-2024. These figures are periodically revised as more complete reports become available. To convey reliable, high-information value, the following table summarizes key metrics by sex and race and ethnicity, using the most recent finalized data at the time of publication. Note that 2023 provisional estimates show some fluctuations, and finalized 2023 data may become available in later reports.

How geography, economics, and health systems shape differences

U.S. female life expectancy is strongly associated with social determinants of health. Higher educational attainment, stable employment, adequate housing, and access to quality medical care are linked to longer lives. Counties with higher incomes, more college graduates, and stronger public health infrastructure tend to have higher longevity, even after accounting for individual behaviors. Conversely, areas with higher poverty, unemployment, and limited health care access often show lower life expectancy. These patterns are not immutable: policy changes, investment in primary care, and community-level interventions can shift trajectories over decades.

Major causes of death and their changing contributions

The leading causes of death among women in the United States shape overall life expectancy trends. Heart disease and cancer have long been the top two causes, followed by chronic lower respiratory diseases, stroke, and Alzheimer disease. Injuries, particularly drug overdoses and motor vehicle crashes, have become increasingly prominent, especially among younger and middle-aged adults. Provisional data through 2022 indicate slight declines in heart disease and cancer death rates, while drug overdose deaths have remained elevated, contributing to slower improvements in life expectancy. Public health efforts that reduce tobacco use, improve early detection, and expand treatment for substance use disorders have repeatedly shown measurable gains in longevity.

Behavior, health care access, and policy levers

Individual behaviors interact with structural factors to influence female longevity. Tobacco use, diet quality, physical activity, and alcohol consumption affect risk for heart disease, cancer, and diabetes. Timely access to preventive services, such as cancer screening and vaccination, can lower mortality from treatable conditions. Health care system factors, including insurance coverage, affordability, and the availability of providers, also matter: areas with higher rates of uninsured adults or primary care shortages often show worse outcomes. Policy measures—such as Medicaid expansion, public health funding, and paid family leave—can meaningfully improve life expectancy, especially for groups facing structural barriers. These relationships are probabilistic and population-level; they describe patterns, not destiny for any single person or community.

International comparisons and context

When compared with other high-income countries, U.S. female life expectancy is generally lower and has been diverging from peer nations since the 1980s. Many comparable countries have achieved more consistent year-over-year improvements, driven by broader access to care, stronger social safety nets, and more consistent public health investment. The U.S. advantage in Hispanic female life expectancy, often called the Hispanic paradox, appears to narrow as acculturation and duration of residence increase, highlighting the role of social and environmental conditions. These comparisons underscore that longevity is shaped not only by biology and individual choices, but by institutions, policies, and societal priorities.

Data limitations and what to watch going forward

Life expectancy estimates are subject to uncertainty, especially for small geographic areas or subgroups. Methodological changes, such as how race and ethnicity are collected and coded, can affect trends over time. The COVID-19 pandemic introduced exceptional mortality that disrupted multi-decade improvements, and its longer-term health, economic, and social effects continue to influence longevity. Future progress will depend on investments in primary care, mental health and addiction services, social support, and policies that reduce inequities. For individuals and communities, understanding these drivers supports more informed decisions about health, residence, and advocacy.

Summary and practical takeaways

Female average life expectancy in the United States is a population-level measure that captures the combined impact of biology, behavior, health care, and social conditions. Recent provisional data show continued recovery but remain below earlier peaks reached before the pandemic. There are meaningful differences by race, ethnicity, and geography, reflecting structural inequities rather than inevitable biological differences. Improvements are possible through public health strategies that address heart disease, cancer, injuries, and social determinants of health. Reliable data sources such as the CDC’s National Center for Health Statistics provide the best available evidence for tracking progress and targeting interventions over the long term.